Peripheral arterial tonometry in assessing endothelial dysfunction in pediatric sickle cell disease

Pediatric Hematology and Oncology

Volumn 26, Issue 8, 2009, Pages 589-596

  Sivamurthy, Krupa M ^a   Dampier, Carlton ^a   MacDermott, Marylou ^a   Maureen, Meier ^a   Cahill, Michele ^a   Hsu, Lewis L ^a  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

EndoPAT; Endothelial dysfunction; Reactive hyperemia index (RHI); Sickle cell disease

Indexed keywords

HYDROXYUREA;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; ENDOTHELIAL DYSFUNCTION; FOREARM BLOOD FLOW; HEMOLYSIS; HUMAN; HYPEREMIA; OXIDATIVE STRESS; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; TONOMETRY;

ADOLESCENT; ANEMIA, SICKLE CELL; ARTERIES; CHILD; ENDOTHELIUM, VASCULAR; GENOTYPE; HEMOGLOBINS; HUMANS; HYPEREMIA; MANOMETRY; OXIDATIVE STRESS; PERIPHERAL VASCULAR DISEASES; RETICULOCYTES; YOUNG ADULT;

EID: 71449111028     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880010903271689     Document Type: Article

References (17)

1. Munzel T, et al. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med. 2008;40:180-196.
2. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115:1285-1295.
3. Yeo, TW, et al. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J ExpMed. 2007;204:2693-2704.
4. Reiter, CD, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8:1383-1389.
5. Drexler, H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis. 1997;39:287-324.
6. Donald, AE, et al. Non-invasive assessment of endothelial function: which technique? J Am Coll Cardiol. 2006;48:1846-1850.
7. Kavazarakis, E, et al. The impact of serum lipid levels on circulating soluble adhesion molecules in childhood. Pediatr Res. 2002;52:454-458.
8. Aslan, M, Freeman BA. Oxidant-mediated impairment of nitric oxide signaling in sickle cell disease-mechanisms and consequences. Cell Mol Biol (Noisy-le-grand). 2004;50:95-105.
9. Gladwin,MT, et al. Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation. 2003;107:271-278.
10. Otto, ME, et al. Early morning attenuation of endothelial function in healthy humans. Circulation. 2004;109:2507-2510.
11. Zawar, SD, et al. Non-invasive detection of endothelial dysfunction in sickle cell disease by Doppler ultrasonography. J Assoc Physicians India. 2005;53:677-680.
12. Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A.Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44:2137-2141.
13. Hamburg NM, Kayes MJ, Larson MG, Vasan RS, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation. 2008;117:2467-2474.
14. Kuvin JT, Mammen A, Mooney P, Alsheikh-Ali AA, Karas RH. Assessment of peripheral vascular endothelial function in the ambulatory setting. Vasc Med. 2007;12:13-16.
15. Endemann, DH, and Schiffrin EL, Endothelial dysfunction. J Am Soc Nephrol. 2004;15:1983-1992.
16. Krajewski, ML, Hsu LL, Gladwin MT. The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology. Am J Physiol Heart Circ Physiol. 2008;295:H4-H7.
17. Krajewski ML, Footman EA, Kim JA, et al. Nitric oxide-mediated blood flow measurements in patients with sickle cell disease. NIH Clinical Research Training Program student poster presentation, May 8, 2007, Bethesda, MD.